Flagship Biosciences
Flagship Biosciences, Offspring Biosciences Form Assay Development Services Alliance
The companies will combine their respective offerings in preclinical and clinical assay development to offer an end-to-end service for customers.
Gestalt Diagnostics Enters Collaborations on Cancer Pathology Testing
In one of its partnerships, Gestalt will work to integrate Flagship Bioscience's machine learning tools to enable cancer biomarker detection.
Indivumed, Flagship Biosciences Partner on Tissue-Based Cancer Diagnostic Services
The companies anticipate providing services that combine Flagship’s biomarker development and Indivumed’s multiplex IHC assay development capabilities.
Predicine, Flagship Biosciences to Provide Combined Service
The companies announced a strategic venture to provide comprehensive biomarker profiling to empower clinical trials in the immuno-oncology space.
In Brief This Week: NAMSA, Flagship Biosciences, And Thermo Fisher
Medical Research Organization NAMSA said this week it has launched its in vitro diagnostic development business to aid manufacturers expedite commercialization of its products.